Author

Xiao-Ting Chen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

ESAM reduces sensitivity to anti-HER2 therapy in HER2-positive breast cancer by activating the mTOR pathway

The findings identify the ESAM/Calnexin/mTOR axis as a candidate biomarker and therapeutic vulnerability in HER2-positive breast cancer and attenuates sensitivity to anti-HER2 therapy.

Xiao-Ting Chen, Xu-Jie Zhou, Y. Sang et al. · Cell Death Discovery · 0 citations

Open access Aug 2026

Decoding age-stratified clinical and molecular heterogeneity in male breast cancer through multiomic profiling.

Objective Age-associated molecular heterogeneity is well described in female breast cancer but remains insufficiently characterized in male breast cancer (MBC). We profiled age-stratified clinical and molecular differences between younger (≤55 years) male breast cancer (YMBC) and older (>55 years) male breast cancer (O...

Zhi-Shuang Gao, Ze-Hao Wang, Yue Zhou et al. · Chinese journal of cancer re... · 0 citations